Industry Funding Opportunities

Deadline: May 30th 2023 FMC is an agricultural sciences company that advances farming through innovative and sustainable crop protection technologies. FMC is looking for technologies and methods for the production of intermediates, 2,7-dimethylnaphthalene [582-16-1] or 2,7-dimethyl-1- bromonaphthalene [37558-62-6], for pesticidal compounds in a cost-effective manner.

Deadline: June 12th 2023 A multinational company with over 170 years experience in the pharmaceutical industry, dedicated to the commercialisation of self-consumption products (non‑prescription drugs and natural products including food supplements) for the health and well-being of people, they are seeking natural ingredients in food grade in order to improve sleep. Melatonin is the most well-known ingredient used in this health category as a sleep inducer with high knowledge of its effectiveness, however there is controversy surrounding the allowed dosage in Europe. For this reason, our client would like to find a substitute of this ingredient, or an ingredient with a similar effectiveness, to maintain or improve sleep induction and decrease night awakening.

Deadline: June 30th 2023 AstraZeneca are seeking proposals from outstanding final year MD and/or PhD students or Postdoctoral Researchers within three years of receiving their advanced postgraduate degree (MD and/or PhD by 31 December 2023). Candidates may be based anywhere in the world and have an innovative idea that could push the boundaries of science, in AstraZeneca’s focus areas of cardiovascular, renal & metabolic diseases, respiratory & immunology, common infectious and rare diseases. AstraZeneca is also interested in new innovative technologies to improve development of novel therapeutics and treatment approaches. Proposals will be critiqued based on scientific merit, and opportunity to create real impact for patients, society and business.

Deadline: May 30th 2023 Wörwag Pharma is seeking novel research and technological developments related to the role of vitamin D in human health, its application in medical therapy and the prevention and treatment of deficiency. The team has a strong interest in developing ground-breaking solutions with novel therapeutic approaches for osteoporosis, osteoarthritis, age-related muscle diseases, immunity, obesity and diabetes.